Skip to main content
D

Divi's Laboratories Ltd. — Investor Relations & Filings

Ticker · DIVISLAB ISIN · INE361B01024 LEI · 335800C1DHFG1C9T1M03 BSE.NS Manufacturing
Filings indexed 567 across all filing types
Latest filing 2023-10-26 Regulatory Filings
Country IN India
Listing BSE.NS DIVISLAB

About Divi's Laboratories Ltd.

https://www.divislabs.com/

Divi's Laboratories Ltd. is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates, specializing in Contract Research and Manufacturing Services (CRAMS) for the global pharmaceutical industry. The company operates through two primary business segments: Generic APIs and Custom Synthesis of APIs and intermediates for discovery-marketed drugs. Its product portfolio includes a wide range of therapeutic areas, with significant market leadership in products such as Naproxen, Dextromethorphan, and Gabapentin. Additionally, the company produces nutraceutical ingredients, including a comprehensive range of carotenoids. Divi's maintains large-scale manufacturing facilities compliant with international regulatory standards, including the USFDA and EU GMP. The organization focuses on process chemistry and efficient large-scale production to support major global pharmaceutical companies in drug development and commercialization.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings
2023-10-26 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-10-10 English
Trading Window
Regulatory Filings
2023-09-30 English
Press Release (Revised)
Regulatory Filings
2023-09-26 English
Press Release
Regulatory Filings
2023-09-26 English
Resignation
Regulatory Filings
2023-08-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.